Collins Says NIH March-In-Rights Do Not Apply In Cases Of High Prices

November 30, 2017
NIH head Francis Collins threw cold water on advocates' and lawmakers' calls for the agency to utilize its so-called march-in rights created by the Bayh-Dole Act in response to high drug prices. The agency head said the law only applies in cases when the tax-payer funded drugs are not available whatsoever. Under the act, when taxpayer-funded research is used in part to develop a new patent, the agency that helped develop the patent can require it be licensed to a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.